Tempus AI is a precision-medicine company that uses AI and a large library of clinical and molecular data to support cancer and other disease diagnostics and treatment decisions.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Paul Tudor Jones / Tudor | 63 | Added +325% | 802,400 | $46,483,032 | 0.1% |
| Ancora | 40 | Trimmed -7% | 389 | $22,535 | 0.0% |
| Trade date | Who | Type | Amount | |
|---|---|---|---|---|
| 2026-09-22 | Trump, Donald J President | SELL | $15,001 - $50,000 | PTR |
| 2026-07-01 | Trump, Donald J President | BUY | $15,001 - $50,000 | PTR |
“@munchPRMR Don’t have a directional opinion on $TEM since I haven’t done enough research yet. But I do know Nancy Pelosi usually hits.” post →
| Date | Tweet |
|---|---|
| 2026-02-20 | @munchPRMR Don’t have a directional opinion on $TEM since I haven’t done enough research yet. But I do know Nancy Pelosi usually hits. → · 23 likes · 17,599 views |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.